LUNG SQUAMOUS CELL CARCINOMA
Clinical trials for LUNG SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation boost tested in fight against tough lung cancer
Disease control Recruiting nowThis study is testing if adding two types of radiation therapy to a standard first-line treatment works better for people with advanced squamous cell lung cancer. The standard treatment is an immunotherapy drug (sintilimab) plus chemotherapy. Researchers want to see if adding rad…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New cancer drug targets common genetic pathway in multiple tumors
Disease control Recruiting nowThis study is testing a new drug called TER-2013 in people with advanced solid tumors that have specific genetic changes. The main goals are to find a safe dose and see if the drug can shrink tumors. It is for patients who have run out of standard treatment options.
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Terremoto Biosciences Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first human study of an experimental drug called JMT106 for people with advanced solid tumors, including certain lung and liver cancers. The main goal is to find a safe dose and see how the body handles the drug in about 200 participants who have run out of standard t…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC